Dr Julie Howle

Clinical Senior Lecturer
Surgery, Westmead Clinical School

Telephone +61 2 9845 5200

Map

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Rizos, H., Menzies, A., Pupo, G., Carlino, M., Fung, C., Hyman, J., Haydu, L., Mijatov, B., Becker, T., Boyd, S., Howle, J., Saw, R., Thompson, J., Kefford, R., Scolyer, R., Long, G. (2014). BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact. Clinical Cancer Research, 20(7), 1965-1977. [More Information]
  • Howle, J., Veness, M. (2014). Outcome of Patients with Microscopic and Macroscopic Metastatic Nodal Merkel Cell Carcinoma: An Australian Experience. Dermatologic Surgery, 40(1), 46-51. [More Information]
  • Long, G., Wilmott, J., Haydu, L., Tembe, V., Sharma, R., Rizos, H., Thompson, J., Howle, J., Scolyer, R., Kefford, R. (2013). Effects of BRAF inhibitors on human melanoma tissue before treatment, early during treatment and on progression. Pigment Cell & Melanoma Research, 26(4), 499-508. [More Information]
  • Ghattas, S., Howle, J., Wang, T., Kefford, R., Gruenewald, S. (2013). Intravascular metastatic melanoma: A difficult diagnosis. Australasian Journal of Dermatology, 54(2), 141-143. [More Information]
  • Menzies, A., Haydu, L., Visintin, L., Carlino, M., Howle, J., Thompson, J., Kefford, R., Scolyer, R., Long, G. (2012). Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic Melanoma. Clinical Cancer Research, 18(12), 3242-3249. [More Information]
  • Wilmott, J., Tembe, V., Howle, J., Sharma, R., Thompson, J., Rizos, H., Lo, R., Kefford, R., Scolyer, R., Long, G. (2012). Intratumoral Molecular Heterogeneity in a BRAF-Mutant, BRAF Inhibitor-Resistant Melanoma: A Case Illustrating the Challenges for Personalized Medicine. Molecular Cancer Therapeutics, 11(12), 2704-2708. [More Information]
  • Howle, J., Hughes, T., Gebski, V., Veness, M. (2012). Merkel cell carcinoma: An Australian perspective and the importance of addressing the regional lymph nodes in clinically node-negative patients. Journal Of The American Academy Of Dermatology, 67(1), 33-40. [More Information]
  • Lynnhtun, K., Achan, A., Shingde, M., Howle, J., Sharma, R. (2012). Plexiform fibrohistiocytic tumour: morphological changes and challenges in assessment of recurrent and metastatic lesions. Histopathology, 60(7), 1156-1158. [More Information]
  • Wilmott, J., Long, G., Howle, J., Haydu, L., Sharma, R., Thompson, J., Kefford, R., Hersey, P., Scolyer, R. (2012). Selective BRAF inhibitors induce marked T - cell infiltration into human metastatic melanoma. Clinical Cancer Research, 18(5), 1386-1394. [More Information]
  • Howle, J., Veness, M. (2012). Sentinel lymph node biopsy in patients with Merkel cell carcinoma: An emerging role and the Westmead hospital experience. The Australasian Journal of Dermatology, 53(1), 26-31. [More Information]
  • Veness, M., Howle, J. (2011). Merkel cell carcinoma metastatic to the transverse colon: Disease free after six years - cure or just prolonged remission? Australasian Journal of Dermatology, 52(4), 295-297. [More Information]
  • Goh, A., Howle, J., Hughes, M., Veness, M. (2010). Managing patients with cutaneous squamous cell carcinoma metastatic to the axilla or groin lymph nodes. Australasian Journal of Dermatology, 51(2), 113-117. [More Information]
  • Veness, M., Howle, J. (2010). Patients with clinically node negative extremity Merkel cell carcinoma: The importance of identifying and treating patients with microscopic nodal metastases. Australasian Journal of Dermatology, 51(4), 274-278. [More Information]
  • Howle, J., Morgan, G., Palme, C., Kalnins, I., Veness, M. (2008). Metastatic cutaneous squamous cell carcinoma of the scalp. ANZ Journal of Surgery, 78(6), 449-453. [More Information]

2014

  • Rizos, H., Menzies, A., Pupo, G., Carlino, M., Fung, C., Hyman, J., Haydu, L., Mijatov, B., Becker, T., Boyd, S., Howle, J., Saw, R., Thompson, J., Kefford, R., Scolyer, R., Long, G. (2014). BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact. Clinical Cancer Research, 20(7), 1965-1977. [More Information]
  • Howle, J., Veness, M. (2014). Outcome of Patients with Microscopic and Macroscopic Metastatic Nodal Merkel Cell Carcinoma: An Australian Experience. Dermatologic Surgery, 40(1), 46-51. [More Information]

2013

  • Long, G., Wilmott, J., Haydu, L., Tembe, V., Sharma, R., Rizos, H., Thompson, J., Howle, J., Scolyer, R., Kefford, R. (2013). Effects of BRAF inhibitors on human melanoma tissue before treatment, early during treatment and on progression. Pigment Cell & Melanoma Research, 26(4), 499-508. [More Information]
  • Ghattas, S., Howle, J., Wang, T., Kefford, R., Gruenewald, S. (2013). Intravascular metastatic melanoma: A difficult diagnosis. Australasian Journal of Dermatology, 54(2), 141-143. [More Information]

2012

  • Menzies, A., Haydu, L., Visintin, L., Carlino, M., Howle, J., Thompson, J., Kefford, R., Scolyer, R., Long, G. (2012). Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic Melanoma. Clinical Cancer Research, 18(12), 3242-3249. [More Information]
  • Wilmott, J., Tembe, V., Howle, J., Sharma, R., Thompson, J., Rizos, H., Lo, R., Kefford, R., Scolyer, R., Long, G. (2012). Intratumoral Molecular Heterogeneity in a BRAF-Mutant, BRAF Inhibitor-Resistant Melanoma: A Case Illustrating the Challenges for Personalized Medicine. Molecular Cancer Therapeutics, 11(12), 2704-2708. [More Information]
  • Howle, J., Hughes, T., Gebski, V., Veness, M. (2012). Merkel cell carcinoma: An Australian perspective and the importance of addressing the regional lymph nodes in clinically node-negative patients. Journal Of The American Academy Of Dermatology, 67(1), 33-40. [More Information]
  • Lynnhtun, K., Achan, A., Shingde, M., Howle, J., Sharma, R. (2012). Plexiform fibrohistiocytic tumour: morphological changes and challenges in assessment of recurrent and metastatic lesions. Histopathology, 60(7), 1156-1158. [More Information]
  • Wilmott, J., Long, G., Howle, J., Haydu, L., Sharma, R., Thompson, J., Kefford, R., Hersey, P., Scolyer, R. (2012). Selective BRAF inhibitors induce marked T - cell infiltration into human metastatic melanoma. Clinical Cancer Research, 18(5), 1386-1394. [More Information]
  • Howle, J., Veness, M. (2012). Sentinel lymph node biopsy in patients with Merkel cell carcinoma: An emerging role and the Westmead hospital experience. The Australasian Journal of Dermatology, 53(1), 26-31. [More Information]

2011

  • Veness, M., Howle, J. (2011). Merkel cell carcinoma metastatic to the transverse colon: Disease free after six years - cure or just prolonged remission? Australasian Journal of Dermatology, 52(4), 295-297. [More Information]

2010

  • Goh, A., Howle, J., Hughes, M., Veness, M. (2010). Managing patients with cutaneous squamous cell carcinoma metastatic to the axilla or groin lymph nodes. Australasian Journal of Dermatology, 51(2), 113-117. [More Information]
  • Veness, M., Howle, J. (2010). Patients with clinically node negative extremity Merkel cell carcinoma: The importance of identifying and treating patients with microscopic nodal metastases. Australasian Journal of Dermatology, 51(4), 274-278. [More Information]

2008

  • Howle, J., Morgan, G., Palme, C., Kalnins, I., Veness, M. (2008). Metastatic cutaneous squamous cell carcinoma of the scalp. ANZ Journal of Surgery, 78(6), 449-453. [More Information]

To update your profile click here. For support on your academic profile contact .